Alere
51 Sawyer Road
Suite 200
Waltham
Massachusetts
02453-3448
United States
Tel: 781-647-3900
Website: http://www.alere.com/
About Alere
Alere delivers immediate and actionable information through rapid diagnostic tests, resulting in better economic and healthcare outcomes globally. The Alere global leading rapid diagnostic products and services, as well as its new product development efforts, focus on infectious disease, cardiometabolic disease and toxicology
YEAR FOUNDED:
May 11, 2001
LEADERSHIP:
Founder: Ronald Zwanziger
CEO: Namal Nawana
JOBS:
Please click here for Alere job opportunities.
FOLLOW ALERE:
Tweets by Alere
315 articles about Alere
-
Alere Launches Alere iCup Rx Drug Screen For Detecting Commonly Misused And Abused Prescription Drugs
7/19/2017
-
Abbott Commences Cash Tender Offer For All Outstanding Shares Of Series B Convertible Perpetual Preferred Stock Of Alere
7/17/2017
-
Alere Shareholders Approve Amended Merger With Abbott
7/10/2017
-
Alere Declares Cash Dividend On Its Series B Convertible Perpetual Preferred Stock
6/26/2017
-
Alere Says Feds Closed an Investigation in Billing Probe
6/16/2017
-
Alere Reports First Quarter 2017 Financial Results
6/15/2017
-
Alere Files Form 10-K, Reports Fourth Quarter And Full Year 2016 Financial Results
6/6/2017
-
Alere Announces Termination Of Consent Solicitations For Alere's Notes And Offers Consent Termination Fee
6/6/2017
-
Alere Announces Commencement Of Additional Consent Solicitations For Alere's Notes
6/1/2017
-
How Abbott Will Benefit From Its Alere Acquisition
5/26/2017
-
Alere Announces Update On Form 10-K And Provides Preliminary Unaudited Financial Results
5/22/2017
-
Alere Announces Successful Completion Of Consent Solicitations For Alere's Notes
5/9/2017
-
Alere Announces Modifications Of Consent Solicitations For Alere's Notes
5/4/2017
-
Alere Announces Commencement Of Consent Solicitations For Alere's Notes
5/1/2017
-
Alere Launches The Alere Malaria Ag P.F, The First-Ever Rapid Test To Screen Malaria Infection In Asymptomatic Individuals
4/25/2017
-
Abbott CEO Remains Optimistic on Alere Buy
4/24/2017
-
Abbott Seals Alere Deal at Lower Price, Ending Legal Battle
4/14/2017
-
Alere Achieves FDA Clearance for Alere Reader Platform and Alere BinaxNOW Influenza A & B Card 2
4/11/2017
-
Embattled Alere Out of Compliance With NYSE Listing Rules
3/23/2017
-
Alere Declares Cash Dividend On Its Series B Convertible Perpetual Preferred Stock
3/21/2017